» Articles » PMID: 27365992

Evaluating the Anticancer Potential of Ethanolic Gall Extract of Terminalia Chebula (Gaertn.) Retz. (Combretaceae)

Overview
Date 2016 Jul 2
PMID 27365992
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Plants have been an important source for discovery of anticancer compounds. With the current decline in the number of new molecular entities from the pharmaceutical industry, novel anticancer agents are being sought from traditional medicines; therefore the anticancer efficacy of many plants that are used in traditional medicine is yet to be verified. The objective of the study was to evaluate the cytotoxic potential of ethanolic leaf gall extract of Terminalia chebula are evaluated against buffalo rat liver 3A, MCF-7 (Human mammary gland adenocarcinoma) and A-549 (Human lung cancer) cell lines. The cytotoxic effect of the ethanolic extract was evaluated by MTT assay. The extract was potent and effective in inducing cytotoxic effects in all the cell lines with an IC50 value of 305.18 ± 1.7 μg/mL, 643.13 ± 4.2 μg/mL, and 208.16 ± 3.7 μ/mL, respectively. The extract was more effective against A549 cell lines when compared to others. The presences of phenolics, triterpenoids, and flavonoids were identified in the extract. The extract showed total phenolic and flavonoid content of 478 ± 2.2 mg of gallic acid equivalent/g d.w and 538 ± 1.4 mg of quercetinequivalent/g d.w, respectively. This higher content of total phenolics and flavonoids found in the ethanolic extract was directly associated to higher cytotoxicity activity.

Conclusion: The ethanolic leaf gall extract of T. chebula showed effective cytotoxic activities; which might be attributed to the phenolics/flavonoids present in higher concentration. Future work will be interesting to know the chemical composition of the extract and also better understand the mechanism of action of the constituents present in the extract to develop it as drug for therapeutic application.

Summary: The present investigation establishes the anticancer activities of T. chebula leaf gall extracts on BRL3A, MCF-7, and A-549 cells. Presumably, these activities could be attributed in part to the phenolics/flavanoids features of the extract that has been demonstrated to act as cytotoxic agents. The experimental evidence obtained in the laboratory model could provide a rationale for the traditional use of plant as a source of easily available effective anticancer agents to the people, particularly in developing countries.

Citing Articles

Traditional Tibetan medicine: therapeutic potential in lung diseases.

Li C, Li Y, Huang X, Li S, Sangji K, Gu R Front Pharmacol. 2024; 15:1365911.

PMID: 38567353 PMC: 10986185. DOI: 10.3389/fphar.2024.1365911.


A Polyherbal Formulation Habb-e-Ustukhuddus Induces Apoptosis and Inhibits Cell Migration in Lung and Breast Cancer Cells without Any Toxicity in Mice.

Punia R, Ali M, Shamsi Y, Singh R Asian Pac J Cancer Prev. 2023; 24(8):2713-2727.

PMID: 37642058 PMC: 10685228. DOI: 10.31557/APJCP.2023.24.8.2713.


The therapeutic mechanism of in the treatment of immunosuppression in Chinese yellow quail on the basis of network pharmacology.

Wu Q, He M, Wang J, Tong T, Yang D, Tang H Front Vet Sci. 2023; 10:1123449.

PMID: 37275616 PMC: 10235497. DOI: 10.3389/fvets.2023.1123449.


Extraction, phytochemical characterization and anti-cancer mechanism of Haritaki churna: An ayurvedic formulation.

Khan M, Yanase E, Trivedi V PLoS One. 2023; 18(5):e0286274.

PMID: 37256897 PMC: 10231837. DOI: 10.1371/journal.pone.0286274.


Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma .

Suo H, Hochnadel I, Petriv N, Franke R, Schmidt J, Limanska N Front Pharmacol. 2022; 13:906468.

PMID: 36172191 PMC: 9511410. DOI: 10.3389/fphar.2022.906468.


References
1.
Sergediene E, Jonsson K, Szymusiak H, Tyrakowska B, Rietjens I, Cenas N . Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships. FEBS Lett. 2000; 462(3):392-6. DOI: 10.1016/s0014-5793(99)01561-6. View

2.
Saleem A, Husheem M, Harkonen P, Pihlaja K . Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol. 2002; 81(3):327-36. DOI: 10.1016/s0378-8741(02)00099-5. View

3.
Reddy L, Odhav B, Bhoola K . Natural products for cancer prevention: a global perspective. Pharmacol Ther. 2003; 99(1):1-13. DOI: 10.1016/s0163-7258(03)00042-1. View

4.
Vonshak A, Barazani O, Sathiyamoorthy P, Shalev R, Vardy D, Golan-Goldhirsh A . Screening South Indian medicinal plants for antifungal activity against cutaneous pathogens. Phytother Res. 2003; 17(9):1123-5. DOI: 10.1002/ptr.1399. View

5.
Cragg G, Newman D . Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005; 100(1-2):72-9. DOI: 10.1016/j.jep.2005.05.011. View